An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)
暂无分享,去创建一个
M. Hallek | A. Rubbert | C. Lehmann | I. Haase | A. Perniok | N. Jung | M. Hellmann | R. Hoheisel